文献速递肺栓塞与肺血管病

CILP1作为肺动脉高压右心室适应不良的生物标志物

CILP1 as a biomarker for right ventricular maladaptation in pulmonary hypertension.
PubMed 文献 · Eur Respir J · 2021-04-01

研究在小鼠肺动脉环缩模型中分析CILP1蛋白表达,并在161例患者中检测血清CILP1。结果显示CILP1对肺动脉高压患者右心室适应不良具有良好预测价值(AUC 0.79),与NT-proBNP无显著差异,高CILP1与右心室-动脉耦联受损相关。

要点

  • 血清CILP1在肺动脉高压伴右心室适应不良患者中升高,对适应不良右心室预测AUC为0.79。
  • CILP1预测效能与NT-proBNP(AUC 0.82)无显著差异。
  • CILP1≥4373 pg·mL-1与更低的TAPSE/PASP比值和更高的NT-proBNP相关。

核心结论

  • CILP1是反映右心室和左心室病理性重构的新生物标志物,与肺动脉高压患者右心室适应不良及心室-动脉耦联受损相关。

研究设计与样本

  • 小鼠肺动脉环缩模型14只,假手术9只,用Western blotting和免疫染色分析心脏CILP1蛋白表达。
  • 检测161例患者血清CILP1:97例肺动脉高压所致右心室压力负荷(适应与适应不良)、25例左心室肥厚、20例扩张型心肌病、19例无左右心室异常对照。

主要发现

  • 小鼠肺动脉环缩后右心室CILP1蛋白量明显高于假手术。
  • 对照组患者血清CILP1水平低于所有其他组(p<0.001)。
  • 肺动脉高压伴右心室适应不良患者CILP1浓度高于适应良好者(p<0.001)、左心室压力负荷者(p<0.001)和扩张型心肌病者(p=0.003)。
  • ROC分析显示CILP1对右心室适应不良预测AUC为0.79,与NT-proBNP的AUC 0.82无显著差异。
  • 高CILP1(右心室适应不良截断值≥4373 pg·mL-1)与更低的TAPSE/PASP比值(p<0.001)和更高NT-proBNP水平(p<0.001)相关。

关键数值与推荐

  • 右心室适应不良的CILP1截断值为≥4373 pg·mL-1。
  • CILP1预测右心室适应不良的AUC为0.79,NT-proBNP的AUC为0.82,两者无显著差异。

临床怎么用

  • CILP1可作为肺动脉高压患者右心室适应不良的辅助生物标志物,帮助识别心室-动脉耦联受损患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The aim of our study was to analyse the protein expression of cartilage intermediate layer protein (CILP)1 in a mouse model of right ventricular (RV) pressure overload and to evaluate CILP1 as a biomarker of cardiac remodelling and maladaptive RV function in patients with pulmonary hypertension (PH).Pulmonary artery banding was performed in 14 mice; another nine mice underwent sham surgery. CILP1 protein expression was analysed in all hearts using Western blotting and immunostaining. CILP1 serum concentrations were measured in 161 patients (97 with adaptive and maladaptive RV pressure overload caused by PH; 25 with left ventricular (LV) hypertrophy; 20 with dilative cardiomyopathy (DCM); 19 controls without LV or RV abnormalities)In mice, the amount of RV CILP1 was markedly higher after banding than after sham. Control patients had lower CILP1 serum levels than all other groups (p<0.001). CILP1 concentrations were higher in PH patients with maladaptive RV function than those with adaptive RV function (p<0.001), LV pressure overload (p<0.001) and DCM (p=0.003). CILP1 showed good predictive power for maladaptive RV in receiver operating characteristic analysis (area under the curve (AUC) 0.79). There was no significant difference between the AUCs of CILP1 and N-terminal pro-brain natriuretic peptide (NT-proBNP) (AUC 0.82). High CILP1 (cut-off value for maladaptive RV of ≥4373 pg·mL-1) was associated with lower tricuspid annular plane excursion/pulmonary artery systolic pressure ratios (p<0.001) and higher NT-proBNP levels (p<0.001).CILP1 is a novel biomarker of RV and LV pathological remodelling that is associated with RV maladaptation and ventriculoarterial uncoupling in patients with PH.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Keranov S, Dörr O, Jafari L, et al. CILP1 as a biomarker for right ventricular maladaptation in pulmonary hypertension. Eur Respir J. 2021. PMID: 33184116. doi:10.1183/13993003.01192-2019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。